734-936-8000 - Service Desk | Request Support

MC3 Recorded Education Series: Depression in Youth: Presentation, Diagnosis and Treatment

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Evaluation
Release Date: Wed, 1/1/20
Termination Date: Thu, 12/31/20
Credits: 1
Description: This presentation on depression in youth will close the practice knowledge gap as it relates to the presentation of depression in youth, clarifying the diagnosis of depression in youth, and identifying appropriate treatments for depression in youth. Viewers will learn strategies for engaging patients and parents to better understand their symptoms and experience. This additional information will inform diagnosis and treatment recommendations.
Educational Objectives: Through this education activity, participants will become more comfortable discussing, diagnosing and treating depression in youth within their medical practices. There will be subsequent improvement in outcomes for the patient, parents and providers.
Target Audience: This activity is appropriate for House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers in the fields of Adolescent Medicine, Family Medicine, Pediatrics, Primary Care, Psychiatry, Psychology, Social Work.
Accreditation Information:

Accreditation and Credit Designation



The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The University of Michigan Medical School designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Release Date: 05/03/19

Termination Date: 04/30/22

Additional Info: Presenter:
Richard Dopp, MD

Educational Planner
Richard Dopp, MD

Educational Co-Planner
Erin Hughes-Krieger, MSW
Associate Program Manager
Anne Kramer, MSW

*Financial Disclosures:
There are no relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.

References:
Prevention of Depression in At-Risk Adolescents A Randomized Controlled Trial
Judy Garber, PhD; Gregory N. Clarke, PhD; V. Robin Weersing, PhD; et al. JAMA. 2009;301(21):2215-2224. doi:10.1001/jama.2009.788

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
David Brent, MD; Graham Emslie, MD; Greg Clarke, PhD; et al. JAMA. 2008 Feb 27;299(8):901-13. doi: 10.1001/jama.299.8.901.

Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings.
Kennard BD1, Clarke GN, Weersing VR, Asarnow JR, Shamseddeen W, Porta G, Berk M, Hughes JL, Spirito A, Emslie GJ, Keller MB, Wagner KD, Brent DA.
J Consult Clin Psychol. 2009 Dec;77(6):1033-41. doi: 10.1037/a0017411.

Credits available:

AMA PRA Category 1: 1.00
Participation: 1.00